Published in Antimicrob Agents Chemother on February 01, 1987
Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother (1997) 2.91
Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (2001) 2.46
Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother (2002) 2.11
Haemophilus influenzae: antibiotic susceptibility. Clin Microbiol Rev (1988) 1.76
Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother (1992) 1.55
Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities. Antimicrob Agents Chemother (1988) 1.04
Modification in penicillin-binding proteins during in vivo development of genetic competence of Haemophilus influenzae is associated with a rapid change in the physiological state of cells. Infect Immun (1992) 0.96
Effect of beta-lactams on peptidoglycan metabolism of Haemophilus influenzae grown in animals. Antimicrob Agents Chemother (1992) 0.77
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol (1973) 33.51
A small cosmid for efficient cloning of large DNA fragments. Gene (1980) 22.61
Properties of the penicillin-binding proteins of Escherichia coli K12,. Eur J Biochem (1977) 16.26
Defined nongrowth media for stage II development of competence in Haemophilus influenzae. J Bacteriol (1970) 8.51
Extracellular nucleases of pseudomonas BAL 31. III. Use of the double-strand deoxyriboexonuclease activity as the basis of a convenient method for the mapping of fragments of DNA produced by cleavage with restriction enzymes. Nucleic Acids Res (1978) 5.62
Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J Clin Microbiol (1984) 5.09
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Interaction of FtsA and PBP3 proteins in the Escherichia coli septum. J Bacteriol (1986) 2.82
Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob Agents Chemother (1984) 2.65
Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol. Pediatrics (1980) 2.43
Mechanisms of ampicillin resistance in Haemophilus influenzae from respiratory tract. Lancet (1980) 2.16
Resistance to beta-lactam antibiotics by re-modelling the active site of an E. coli penicillin-binding protein. Nature (1986) 1.87
beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrob Agents Chemother (1981) 1.82
Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. Pediatrics (1982) 1.64
Amino acid substitutions that reduce the affinity of penicillin-binding protein 3 of Escherichia coli for cephalexin. Eur J Biochem (1985) 1.49
Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Antimicrob Agents Chemother (1986) 1.41
Increasing ampicillin-resistance rates in Hemophilus influenzae meningitis. Am J Dis Child (1984) 1.25
Differential behavior of plasmids containing chromosomal DNA insertions of various sizes during transformation and conjugation in Haemophilus influenzae. J Bacteriol (1985) 1.04
Antibiotic resistance and Haemophilus influenzae. J Antimicrob Chemother (1984) 0.97
Epiglottitis due to ampicillin-tolerant Haemophilus influenzae type b. South Med J (1984) 0.82
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54
Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother (1977) 4.11
Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol (1991) 3.13
Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 3.01
Transferable drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1972) 2.83
Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob Agents Chemother (1984) 2.65
Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother (1983) 2.58
Bacterial transferrin and lactoferrin receptors. Trends Microbiol (1996) 2.53
Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrob Agents Chemother (1994) 2.47
Task-related circuit training improves performance of locomotor tasks in chronic stroke: a randomized, controlled pilot trial. Arch Phys Med Rehabil (2000) 2.46
Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J Bacteriol (1988) 2.35
Accumulation of enoxacin by Escherichia coli and Bacillus subtilis. Antimicrob Agents Chemother (1987) 2.26
Characteristics of R931 and other Pseudomonas aeruginosa R factors. Antimicrob Agents Chemother (1973) 2.24
Gentamicin accumulation by sensitive strains of Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) (1975) 2.21
Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene (1993) 2.19
Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 2.18
Transferable chloramphenicol and ampicillin resistance in a strain of Haemophilus influenzae. Antimicrob Agents Chemother (1978) 2.18
Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.16
Potential role of mental practice using motor imagery in neurologic rehabilitation. Arch Phys Med Rehabil (2001) 2.13
Gentamicin resistance in Pseudomonas aeruginosa: R-factor-mediated resistance. Antimicrob Agents Chemother (1974) 2.13
Comparison of a slide blood culture system with a supplemented peptone broth culture method. J Clin Microbiol (1981) 2.12
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother (1989) 2.05
Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun (1995) 2.05
Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother (1995) 1.94
Frontal and sagittal plane analyses of the stair climbing task in healthy adults aged over 40 years: what are the challenges compared to level walking? Clin Biomech (Bristol, Avon) (2003) 1.94
In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J Infect Dis (1991) 1.90
Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.88
Effect of enzymatic adenylylation on dihydrostreptomycin accumulation in Escherichia coli carrying an R-factor: model explaining aminoglycoside resistance by inactivating mechanisms. Antimicrob Agents Chemother (1978) 1.86
beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrob Agents Chemother (1981) 1.82
Further properties of P-2 R-factors of Pseudomonas aeruginosa and their relationship to other plasmid groups. Can J Microbiol (1975) 1.79
Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1972) 1.78
Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant (1994) 1.78
Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine (1993) 1.75
Penicillin-binding components of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother (1980) 1.72
Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome c552 and nitrate reductase. Antimicrob Agents Chemother (1980) 1.69
Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae. Mol Microbiol (1988) 1.69
Identification and characterization of genes encoding the human transferrin-binding proteins from Haemophilus influenzae. Infect Immun (1995) 1.68
Preparation and analysis of isogenic mutants in the transferrin receptor protein genes, tbpA and tbpB, from Neisseria meningitidis. Mol Microbiol (1993) 1.66
Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother (1992) 1.55
Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification. J Antibiot (Tokyo) (1976) 1.47
Identification and characterization of a porcine-specific transferrin receptor in Actinobacillus pleuropneumoniae. Mol Microbiol (1990) 1.46
The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Infect Immun (1998) 1.46
Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency. J Antimicrob Chemother (1990) 1.45
Iron acquisition in Pasteurella haemolytica: expression and identification of a bovine-specific transferrin receptor. Infect Immun (1990) 1.42
Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Antimicrob Agents Chemother (1986) 1.41
Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39
Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.39
Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase. Antimicrob Agents Chemother (1991) 1.37
Walking speed over 10 metres overestimates locomotor capacity after stroke. Clin Rehabil (2001) 1.36
Categorization of clinical isolates of Helicobacter pylori on the basis of restriction digest analyses of polymerase chain reaction-amplified ureC genes. J Clin Microbiol (1993) 1.36
Biochemical characterization of a Haemophilus influenzae periplasmic iron transport operon. J Biol Chem (1995) 1.35
In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria. Antimicrob Agents Chemother (2001) 1.34
Use of biotinylated beta-lactams and chemiluminescence for study and purification of penicillin-binding proteins in bacteria. Antimicrob Agents Chemother (1994) 1.29
Task-specific physical therapy for optimization of gait recovery in acute stroke patients. Arch Phys Med Rehabil (1993) 1.28
Sequence, genetic analysis, and expression of Actinobacillus pleuropneumoniae transferrin receptor genes. Microbiology (1995) 1.28
Three-dimensional gait analysis in women with a total hip arthroplasty. Clin Biomech (Bristol, Avon) (2000) 1.27
Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport. Antimicrob Agents Chemother (1981) 1.27
Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy. Antimicrob Agents Chemother (1991) 1.24
Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J Infect Dis (1985) 1.23
Classification of R plasmids by incompatibility in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.23
Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve (1992) 1.23
Gait in stroke: assessment and rehabilitation. Clin Geriatr Med (1999) 1.20
Iron transport-mediated drug delivery using mixed-ligand siderophore-beta-lactam conjugates. Chem Biol (1996) 1.19
Distribution of porin and lipopolysaccharide antigens on a Pseudomonas aeruginosa permeability mutant. Antimicrob Agents Chemother (1986) 1.19
Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun (1997) 1.18
Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically. J Antimicrob Chemother (1981) 1.15
The interaction of primate transferrins with receptors on bacteria pathogenic to humans. Microb Pathog (1993) 1.15
Transformation of Pseudomonas aeruginosa by electroporation. Anal Biochem (1990) 1.14
Lipopolysaccharide composition of three strains of Haemophilus influenzae. Can J Microbiol (1984) 1.14
Bacterial phylogenetic clusters revealed by genome structure. J Bacteriol (1999) 1.13
Penetration of beta-lactams through Pseudomonas aeruginosa porin channels. Antimicrob Agents Chemother (1987) 1.12
Hip-spine movement interaction and muscle activation patterns during sagittal trunk movements in low back pain patients. Spine (Phila Pa 1976) (1994) 1.12
Response of Haemophilus somnus to iron limitation: expression and identification of a bovine-specific transferrin receptor. Microb Pathog (1990) 1.12
Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal beta-lactamase to piperacillin, ceftazidime, and cefsulodin. Antimicrob Agents Chemother (1984) 1.11
Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc (1992) 1.11
Locomotor-specific measure of spasticity of plantarflexor muscles after stroke. Arch Phys Med Rehabil (2001) 1.11
Mechanisms of disturbed motor control in ankle weakness during gait after stroke. Gait Posture (2002) 1.11
Characteristics of PR5, a lipid-containing plasmid-dependent phage. Can J Microbiol (1978) 1.11
Discrimination between apo and iron-loaded forms of transferrin by transferrin binding protein B and its N-terminal subfragment. Microb Pathog (1998) 1.10
Cloning and sequence analysis of the fur gene encoding an iron-regulatory protein of Neisseria meningitidis. Gene (1994) 1.10
Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb Pathog (1999) 1.09
Biochemical analysis of lactoferrin receptors in the Neisseriaceae: identification of a second bacterial lactoferrin receptor protein. Microb Pathog (1995) 1.09
Coactivation during gait as an adaptive behavior after stroke. J Electromyogr Kinesiol (2000) 1.08
Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin. Antimicrob Agents Chemother (1989) 1.08
DNA probe technology for rapid detection of Haemophilus influenzae in clinical specimens. J Clin Microbiol (1988) 1.08
N-linked oligosaccharides of human transferrin are not required for binding to bacterial transferrin receptors. Infect Immun (1990) 1.07
The interaction between human transferrin and transferrin binding protein 2 from Moraxella (Branhamella) catarrhalis differs from that of other human pathogens. Microb Pathog (1993) 1.07
Modification of postural responses and step initiation: evidence for goal-directed postural interactions. J Neurophysiol (1994) 1.06
The effect of complement and other cell wall reagents on tetracycline and streptomycin resistance in Pseudomonas aeruginosa. Can J Microbiol (1974) 1.06
The region of human transferrin involved in binding to bacterial transferrin receptors is localized in the C-lobe. Mol Microbiol (1993) 1.06
Increase of capsular material thickness following in vivo growth of virulent Streptococcus suis serotype 2 strains. FEMS Microbiol Lett (1994) 1.05
Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin-binding protein B. Mol Microbiol (1999) 1.05
Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities. Antimicrob Agents Chemother (1988) 1.04
Characterization of Moraxella (Branhamella) catarrhalis lbpB, lbpA, and lactoferrin receptor orf3 isogenic mutants. Infect Immun (1999) 1.02
Relationship between gentamicin susceptiblity criteria and therapeutic serum levels for Pseudomonas aeruginosa in mouse infection model. Antimicrob Agents Chemother (1978) 1.02
Preparation and characterization of Neisseria meningitidis mutants deficient in production of the human lactoferrin-binding proteins LbpA and LbpB. J Bacteriol (1998) 1.01
Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes. Infect Immun (1998) 1.01
Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis. Microb Pathog (1998) 1.01